Author: Ken Dropiewski

LindaCare to Debut ProPulse™ Cardiac Remote Monitoring Services at ACC in New Orleans

LEUVEN, Belgium and HARTFORD, Conn., March 14, 2019 /PRNewswire/ — LindaCare, a digital health company specializing in remote patient monitoring solutions for chronic disease management, today announced the company will offer ProPulse™, a new remote monitoring service for patients with cardiac implantable devices, adding to its online device management software solution. Dr. Robert Lerman, LindaCare’s Chief […]

BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease

FRANKLIN LAKES, N.J., March 14, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration has granted premarket approval for the Venovo™ venous stent, the first stent indicated to treat iliofemoral venous occlusive disease, which is obstructed or narrowed blood flow […]

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

SILVER SPRING, Md., March 14, 2019 /PRNewswire/ — The U.S. Food and Drug Administration today approved a new indication for a heart valve repair device that is intended to reduce moderate-to-severe or severe mitral regurgitation, a leakage of blood backward through the mitral valve into the heart’s left atrium that can cause […]


ABBOTT PARK, Ill., March 14, 2019 /PRNewswire/ — Abbott (NYSE: ABT) today announced it received approval from the U.S. Food and Drug Administration (FDA) for a new, expanded indication to its leading MitraClip™ device used to repair a leaky mitral valve without open-heart surgery. Supported by the results of the landmark COAPT™ Trial, […]

eMurmur Announces Launch of Its eMurmur Heartpedia App

OTTAWA, Ontario–(BUSINESS WIRE)–eMurmur today announced the release of eMurmur Heartpedia, an app designed to help patients, parents and medical professionals better understand heart defects through anatomically-correct 3D models and corresponding heart and murmur sound recordings for each defect. eMurmur Heartpedia is a major upgrade to the original Heartpedia app from […]

Level Ex® Turns the Practice of Cardiology into a Video Game with Launch of Cardio ExTM

CHICAGO–(BUSINESS WIRE)–Level Ex, creators of industry-leading medical video games for physicians, today announced its expansion into cardiology with the launch of Cardio Ex. Their fourth specialty game, available free in the App Store, presents interventional cardiologists with adrenaline-pumping scenarios that push their cognitive, spatial-reasoning, and decision-making skills to the limits—preparing […]

Tenaya Therapeutics Strengthens Leadership Team with Appointment of Two Biopharmaceutical Industry Veterans

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tenaya Therapeutics, a biopharmaceutical company focused on developing potentially curative treatments for heart disease, today announced that it has strengthened its leadership team with the appointment of Whittemore Tingley, M.D., Ph.D., as Chief Medical Officer, and Kee-Hong Kim, Ph.D., as Senior Vice President of Manufacturing and […]

Conavi Medical Announces Health Canada Approval of Novasight Hybrid System for Visualization During Coronary Angioplasty Procedures

TORONTO–(BUSINESS WIRE)–Conavi Medical Inc. ( is pleased to announce that it has received a Health Canada Medical Device License for the Novasight HybridTM System. This patented technology is the only clinical system that enables simultaneous imaging of coronary arteries with both intravascular ultrasound (IVUS) and optical coherence tomography (OCT), and was […]

Itamar Medical Reports Fourth Quarter and Full Year 2018 Financial Results With Record Revenues

CAESAREA, Israel, March 13, 2019 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq & TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market, today reported its unaudited financial results for the fourth quarter and full year 2018. […]

Caladrius Biosciences to Host 2018 Fourth Quarter and Year End Financial Results Conference Call on Thursday, March 14, 2019 at 4:30 p.m. Eastern Time

BASKING RIDGE, N.J., March 13, 2019 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company committed to the development of innovative products that have the potential to restore the health of people with chronic illnesses and with a focus on select […]